ATE495256T1 - Methode zur identifizierung bakterielle dns - Google Patents

Methode zur identifizierung bakterielle dns

Info

Publication number
ATE495256T1
ATE495256T1 AT01934545T AT01934545T ATE495256T1 AT E495256 T1 ATE495256 T1 AT E495256T1 AT 01934545 T AT01934545 T AT 01934545T AT 01934545 T AT01934545 T AT 01934545T AT E495256 T1 ATE495256 T1 AT E495256T1
Authority
AT
Austria
Prior art keywords
receptor protein
bacterial dna
unmethylated cpg
cpg sequence
sequence
Prior art date
Application number
AT01934545T
Other languages
English (en)
Inventor
Shizuo Akira
Hiroaki Hemmi
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Application granted granted Critical
Publication of ATE495256T1 publication Critical patent/ATE495256T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01934545T 2000-07-19 2001-06-05 Methode zur identifizierung bakterielle dns ATE495256T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000219652A JP2002034565A (ja) 2000-07-19 2000-07-19 細菌ｄｎａを特異的に認識する受容体タンパク質
PCT/JP2001/004731 WO2002006482A1 (en) 2000-07-19 2001-06-05 Receptor protein specifically recognizing bacterial dna

Publications (1)

Publication Number Publication Date
ATE495256T1 true ATE495256T1 (de) 2011-01-15

Family

ID=18714395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01934545T ATE495256T1 (de) 2000-07-19 2001-06-05 Methode zur identifizierung bakterielle dns

Country Status (7)

Country Link
US (1) US7507872B2 (de)
EP (1) EP1302541B1 (de)
JP (1) JP2002034565A (de)
AT (1) ATE495256T1 (de)
CA (1) CA2385302C (de)
DE (1) DE60143845D1 (de)
WO (1) WO2002006482A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035695A2 (en) * 2001-07-26 2003-05-01 Tanox, Inc. Agents that activate or inhibit toll-like receptor 9
ES2266374T3 (es) 2002-09-18 2007-03-01 Sirs-Lab Gmbh Procedimiento para la deteccion de adn procariotico.
WO2004070344A2 (en) * 2003-02-04 2004-08-19 Bayer Healthcare Ag Method of screening for agents which modulate the activity of tlr9
WO2005001116A1 (ja) * 2003-06-17 2005-01-06 Meiji Dairies Corporation Toll様レセプター強制発現細胞の利用
US20050256073A1 (en) * 2004-02-19 2005-11-17 Coley Pharmaceutical Group, Inc. Immunostimulatory viral RNA oligonucleotides
ATE554167T1 (de) 2004-03-05 2012-05-15 Sirs Lab Gmbh Verfahren zur anreicherung und/oder abtrennung von prokaryotischer dna mittels eines proteins, das nicht-methylierte cpg-motive enthaltende dna spezifisch bindet
JP4961556B2 (ja) * 2004-12-09 2012-06-27 国立大学法人大阪大学 ヘモゾイン誘導による自然免疫を利用したマラリア感染症の検出・測定、マラリア感染症の予防又は治療薬のスクリーニング、及び該自然免疫誘導の調節
US20090137024A1 (en) * 2007-11-28 2009-05-28 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA
WO2014174704A1 (ja) * 2013-04-22 2014-10-30 国立大学法人東京大学 炎症性疾患の予防又は治療剤
US10956145B2 (en) * 2019-01-22 2021-03-23 Saudi Arabian Oil Company System and method for determining dynamic dependencies for enterprise it change management, simulation and rollout

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CN101486759A (zh) * 1997-05-07 2009-07-22 先灵公司 人Toll样受体蛋白、相关试剂和方法
JP2002510644A (ja) * 1998-04-03 2002-04-09 ユニバーシティ オブ アイオワ リサーチ ファウンデーション 免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物
US20020012660A1 (en) * 1999-03-04 2002-01-31 Alan Colman Method of preparing a somatic cells for nuclear transfer
GB0001704D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US20030083244A1 (en) 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
CN1721443A (zh) 2000-05-25 2006-01-18 先灵公司 人受体蛋白；相关的试剂和方法
CA2419894A1 (en) * 2000-09-15 2002-03-21 Coley Pharmaceutical Gmbh Process for high throughput screening of cpg-based immuno-agonist/antagonist
AU2001296235A1 (en) 2000-10-12 2002-04-22 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
US20030124655A1 (en) 2003-07-03
DE60143845D1 (de) 2011-02-24
CA2385302C (en) 2009-08-25
US7507872B2 (en) 2009-03-24
WO2002006482A1 (en) 2002-01-24
EP1302541A4 (de) 2005-06-15
JP2002034565A (ja) 2002-02-05
EP1302541B1 (de) 2011-01-12
CA2385302A1 (en) 2002-01-24
EP1302541A1 (de) 2003-04-16

Similar Documents

Publication Publication Date Title
Reid et al. Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy
DE60143845D1 (de) Methode zur Identifizierung BAKTERIELLE DNS
PT1219711E (pt) Vacina de lawsonia intracellularis
DE60220578D1 (de) Methode und Reagenzien zur Analyse der Nukleotidsequenz von Nukleinsäuren
Raszek et al. Use of genomic tools to improve cattle health in the context of infectious diseases
Aboagye-Antwi et al. Experimental swap of Anopheles gambiae's assortative mating preferences demonstrates key role of X-chromosome divergence island in incipient sympatric speciation
Guedes et al. A comparative in silico linear B-cell epitope prediction and characterization for South American and African Trypanosoma vivax strains
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
AR038173A1 (es) Gen dgat polimorfico bovino, marcador del contenido de grasa en leche y del veteado de la carne
Sanchez-Morgado et al. Molecular characterization of a virulent canine coronavirus BGF strain
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
AR020092A1 (es) Una cepa aislada de virus de hepatitis, acido nucleico aislado que codifica un polipeptido de la cepa, vector que comprende dicho acido nucleico, sistemavector huesped para la produccion del polipeptido, el polipeptido, metodo para su produccion, metodo para obtener anticuerpos contra el polipeptido
Coff et al. Draft genome of the bluefin tuna blood fluke, Cardicola forsteri
HUP0104519A2 (hu) Eljárások antigén-szekvenciák azonosítására
Calarco et al. Annotating the ‘hypothetical’in hypothetical proteins: In-silico analysis of uncharacterised proteins for the Apicomplexan parasite, Neospora caninum
Rinaldi et al. Trematode Genomics and Proteomics
Zvi et al. Clusters versus affinity-based approaches in F. tularensis whole genome search of CTL epitopes
de-Dios et al. Bone adhered soil as a source of target and environmental DNA and proteins
DE69940268D1 (de) Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung
Gerber et al. A comparative in silico linear B-cell epitope prediction and characterization
DK1664097T3 (da) Piroplasmidvaccine
EP1237114A3 (de) Verfahren zum Entwerfen von Gensonden und Informationsverarbeitungsvorrichtung
Rodriguez Applications of metagenomics and viral genomics to investigating diseases of livestock
AR020093A1 (es) Una cepa aislada de virus de hepatitis, acido nucleico aislado que codifica un polipeptido de la cepa, vector que comprende dicho acido nucleico, sistemavector huesped para la produccion del polipeptido, el polipeptido, metodo para su produccion, oligonucleotido para hibridarse con el acido nucleico
George et al. Genomic Characterization of Alphacoronavirus from Mops Condylurus Bats, Nigeriagenomic Characterization of Alphacoronavirus from Mops Condylurus Bats, Nigeria

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties